Sunday, September 29, 2024
HomeTagsBronchiolitis obliterans syndrome

bronchiolitis obliterans syndrome

Renovion Receives FDA Fast Track Designation for ARINA-1 for the Prevention of BOS Progression in Lung Transplant Patients

Renovion, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ARINA-1 for the prevention of bronchiolitis obliterans...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics